Drug Development Project Charter
This is a practical guide to building a project charter for a drug development project — the short authorising document that names the sponsor, states the objective and gives the manager authority to run the project, adapted to the realities of developing a pharmaceutical product through regulatory stages.
What a Project Charter is
A project charter is the short authorising document that names the sponsor, states the objective and gives the manager authority to run the project. For the full concept and how it works in general, see Project Charter. On a drug development project it plays the same role, tuned to this kind of work.
Why it matters for a Drug Development project
Drug Development projects live or die on developing a pharmaceutical product through regulatory stages. A well-built project charter gives the team a shared, explicit reference for exactly that — reducing ambiguity, aligning stakeholders, and making problems visible early enough to act. Skipping it, or doing it generically, is how drug development projects drift into avoidable delay and cost.
What to include
- Purpose and business justification
- Objectives and success criteria
- High-level scope (in and out)
- Budget and timeline summary
- Key stakeholders and sponsor sign-off
Drug Development-specific considerations
Tailor the project charter to the risks that most often derail drug development projects:
- Regulatory approval delays
- Trial/validation failures
- Strict GxP compliance
Example
On a real drug development project, the project charter would be shaped by developing a pharmaceutical product through regulatory stages. In particular, it should explicitly account for the project’s biggest risks — regulatory approval delays, trial/validation failures, strict GxP compliance — rather than treating them as afterthoughts.